A retrospective analysis of the relationship between the oral administration of probiotics during pregnancy and the Edinburgh postnatal depression scale at 1 month after delivery

Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychol...

Full description

Saved in:
Bibliographic Details
Published inJournal of Japan Society of Perinatal and Neonatal Medicine Vol. 56; no. 2; pp. 218 - 223
Main Authors Okura, Naofumi, Yoshizato, Toshiyuki, Kawakami, Kosuke
Format Journal Article
LanguageJapanese
Published Japan Society of Perinatal and Neonatal Medicine 2020
一般社団法人 日本周産期・新生児医学会
Subjects
Online AccessGet full text
ISSN1348-964X
2435-4996
DOI10.34456/jjspnm.56.2_218

Cover

Abstract Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychological disorders and/or poor socioeconomic background. Survey using the EPDS was conducted at 1 month after delivery, on all subjects. There were 78 cases in which clostridium butyricum MIYAIRI 588 (CBM588)was administered for 2 weeks or longer during pregnancy for gastro-intestinal symptoms, including constipations, and such symptoms improved after initiation of administration. These cases were defined as a PRO administration group. The EPDS positive group which considered a high risk group for postnatal depression, were defined as those cases having high EPDS scores(≧ 9 points)and/or a score of #10 on the questionnaire of ≧ 1 point. The relationship between oral PRO admini-stration and clinical parameters was analyzed, and included the following 5 para-meters: EPDS positive, elderly pregnancy(≧ 35 years old), maternal obesity(body mass index before pregnancy ≧ 28 kg/m2), gestational diabetes mellitus and preterm birth(< 37 weeks). The statistical analysis was conducted using multivariate logistic analysis with significance of P< 0.05. Results: The related factors for the EPDS positive group were PRO administration during pregnancy, elderly pregnancy and preterm birth(< 37 weeks). Conclusion: There is a possibility that the oral PRO administration during pregnancy may have the positive effect of preventing postnatal depression.
AbstractList Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychological disorders and/or poor socioeconomic background. Survey using the EPDS was conducted at 1 month after delivery, on all subjects. There were 78 cases in which clostridium butyricum MIYAIRI 588 (CBM588)was administered for 2 weeks or longer during pregnancy for gastro-intestinal symptoms, including constipations, and such symptoms improved after initiation of administration. These cases were defined as a PRO administration group. The EPDS positive group which considered a high risk group for postnatal depression, were defined as those cases having high EPDS scores(≧ 9 points)and/or a score of #10 on the questionnaire of ≧ 1 point. The relationship between oral PRO admini-stration and clinical parameters was analyzed, and included the following 5 para-meters: EPDS positive, elderly pregnancy(≧ 35 years old), maternal obesity(body mass index before pregnancy ≧ 28 kg/m2), gestational diabetes mellitus and preterm birth(< 37 weeks). The statistical analysis was conducted using multivariate logistic analysis with significance of P< 0.05. Results: The related factors for the EPDS positive group were PRO administration during pregnancy, elderly pregnancy and preterm birth(< 37 weeks). Conclusion: There is a possibility that the oral PRO administration during pregnancy may have the positive effect of preventing postnatal depression.  【目的】妊娠時におけるプロバイオティクス(PRO)経口投与と産後1カ月のエジンバラ産後うつ病自己評価(EPDS)との関連を後方視的に検討した.【方法】2017年3月から2018年12月に精神疾患合併妊婦,特定妊婦を除く916名を対象に産後1カ月時EPDSを実施した.EPDS陽性は,合計点≧9点あるいは質問事項10番≧1点の場合と定義した.妊娠中CBM588を消化器症状に対し2週間以上投与し,かつ投与開始後消化器症状が改善した78例をPRO投与ありと定義した.PRO投与とEPDS陽性,高齢妊娠,母体肥満,妊娠糖尿病,37週未満の早産の関連につき多変量ロジスティック解析を用いて検討した.有意水準はP<0.05とした.【結果】PRO投与はEPDS陽性,高齢妊娠,早産との関連を認めた.【考察】PRO投与は,産後の抑うつ状態の改善に関与する可能性が示唆された.
Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at 1 month after delivery. Methods: The subjects were 916 cases who delivered in our hospital from March 2017 to December 2018, without psychological disorders and/or poor socioeconomic background. Survey using the EPDS was conducted at 1 month after delivery, on all subjects. There were 78 cases in which clostridium butyricum MIYAIRI 588 (CBM588)was administered for 2 weeks or longer during pregnancy for gastro-intestinal symptoms, including constipations, and such symptoms improved after initiation of administration. These cases were defined as a PRO administration group. The EPDS positive group which considered a high risk group for postnatal depression, were defined as those cases having high EPDS scores(≧ 9 points)and/or a score of #10 on the questionnaire of ≧ 1 point. The relationship between oral PRO admini-stration and clinical parameters was analyzed, and included the following 5 para-meters: EPDS positive, elderly pregnancy(≧ 35 years old), maternal obesity(body mass index before pregnancy ≧ 28 kg/m2), gestational diabetes mellitus and preterm birth(< 37 weeks). The statistical analysis was conducted using multivariate logistic analysis with significance of P< 0.05. Results: The related factors for the EPDS positive group were PRO administration during pregnancy, elderly pregnancy and preterm birth(< 37 weeks). Conclusion: There is a possibility that the oral PRO administration during pregnancy may have the positive effect of preventing postnatal depression.
Author Yoshizato, Toshiyuki
Okura, Naofumi
Kawakami, Kosuke
Author_FL 大蔵 尚文
吉里 俊幸
川上 浩介
Author_FL_xml – sequence: 1
  fullname: 川上 浩介
– sequence: 2
  fullname: 吉里 俊幸
– sequence: 3
  fullname: 大蔵 尚文
Author_xml – sequence: 1
  fullname: Okura, Naofumi
  organization: Department of Obstetrics and Gynecology, National Hospital Organization Kokura Medical Center
– sequence: 1
  fullname: Yoshizato, Toshiyuki
  organization: Department of Obstetrics and Gynecology, School of Medicine, Kurume University
– sequence: 1
  fullname: Kawakami, Kosuke
  organization: Department of Obstetrics and Gynecology, National Hospital Organization Kokura Medical Center
BackLink https://cir.nii.ac.jp/crid/1390004222615375104$$DView record in CiNii
BookMark eNo9kU9P3DAQxa2KSt0C9x596DVb_9_kVoQoRULiwoFbNLEnG6-ydmQb0H4tPiFmF3GZkeb95ulp5ic5CzEgIb84W0ultPmz2-Ul7NfarEUvePuNrISSulFdZ87IikvVNp1RTz_IZc5-YEpttNKcr8jbFU1YUswL2uJfkEKA-ZB9pnGkZcKqzlB8DHnyCx2wvCKGoxATzBTc3gefSzoyHztLioOPxdtM3XPyYVsnuA0Q7KF6u-PqjfNheE7biS4xlwClOjmsXA1XXbKFuQYplNN9DGWiMBZMlZhrwHS4IN9HmDNefvZz8vjv5vH6f3P_cHt3fXXf7FqjGjdIC8KMzhnFWKtG6aQAIezQCcbMRo-Saw2q04jGyM5wC1iRbqiggVaek98n2-B9b_1H5bJjjCkhhOFabjRnqmJ_T9guF9hivyS_h3ToIdUbzNifPtNr04tj4e2XZCdIPQb5DtfHkC0
ContentType Journal Article
Copyright 2020 Journal of Japan Society of Perinatal and Neonatal Medicine
Copyright_xml – notice: 2020 Journal of Japan Society of Perinatal and Neonatal Medicine
DBID RYH
DOI 10.34456/jjspnm.56.2_218
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 妊娠中プロバイオティクス経口投与と産後1カ月におけるエジンバラ産後うつ病自己評価との関連についての後方視的検討
DocumentTitle_FL 妊娠中プロバイオティクス経口投与と産後1カ月におけるエジンバラ産後うつ病自己評価との関連についての後方視的検討
EISSN 2435-4996
EndPage 223
ExternalDocumentID 130007899052
article_jjspnm_56_2_56_218_article_char_en
GroupedDBID .55
3O-
ABJNI
ALMA_UNASSIGNED_HOLDINGS
JMI
JSF
JSH
MOJWN
OK1
RJT
RZJ
X7L
X7M
RYH
ID FETCH-LOGICAL-j864-db3ca26fdd640084f3d32a22cb9200675f3155a495ee663961caed329b3d36a83
ISSN 1348-964X
IngestDate Thu Jun 26 22:15:23 EDT 2025
Wed Sep 03 06:24:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j864-db3ca26fdd640084f3d32a22cb9200675f3155a495ee663961caed329b3d36a83
OpenAccessLink https://www.jstage.jst.go.jp/article/jjspnm/56/2/56_218/_article/-char/en
PageCount 6
ParticipantIDs nii_cinii_1390004222615375104
jstage_primary_article_jjspnm_56_2_56_218_article_char_en
PublicationCentury 2000
PublicationDate 2020
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – year: 2020
  text: 2020
PublicationDecade 2020
PublicationTitle Journal of Japan Society of Perinatal and Neonatal Medicine
PublicationTitleAlternate jjspnm
PublicationTitle_FL 日本周産期・新生児医学会雑誌
jjspnm
PublicationYear 2020
Publisher Japan Society of Perinatal and Neonatal Medicine
一般社団法人 日本周産期・新生児医学会
Publisher_xml – name: Japan Society of Perinatal and Neonatal Medicine
– name: 一般社団法人 日本周産期・新生児医学会
References 1) 竹田省:妊産婦の自殺防止.周産期医学 2017;5:623-7
15) Miyaoka T, Kanayama M, Wake R, et al.:Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder:A prospective open-label trial. Clin Neuropharmacol 2018;41:151-5
3) Tam WH1, Chung T:Psychosomatic disorders in pregnancy. Curr Opin Obstet Gynecol 2007;19:126-32
8) Logan AC, Katzman M:Major depressive disorder:probiotics may be an adjuvant therapy. Med Hypotheses 2005;64:533-8
17) Liu RT, Walsh RFL, Sheehan AE:Prebiotics and probiotics for depression and anxiety:A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev 2019;102:13-23
2) Melville JL, Gavin A, Guo Y, et al.:Depressive disorders during pregnancy:prevalence and risk factors in a large urban sample. Obstet Gynecol 2010;116:1064-70
21) 古賀泰裕:プロバイオティクス・プレバイオティクスの歴史,概念,適応.臨床と研究 2018;95:937-41
5) 岡野禎治,村田真理子,増地聡子,他:日本版エジンバラ産後うつ病自己評価表(EPDS)の信頼性と妥当性.神科診断学 1996;7:525-33
12) 光岡知足:プロバイオティクスの歴史と進化.日本乳酸菌学会誌 2011;22:26-37
19) Myhre R, Brantsæter AL, Myking S, et al.:Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr 2011;93:151-7
6) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5):American Psychiatric Association, 2000.
14) Schroeder FA, Lin CL, Crusio WE, et al.:Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007;62:55-64
16) Slykerman RF, Hood F, Wickens K, et al.:Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: A randomised double-blind placebo-controlled trial. EBioMedicine 2017;24:159-65
4) Lyell DJ, Chambers AS, Steidtmann D, et al.:Antenatal identification of major depressive disorder:a cohort study. Am J Obstet Gynecol 2012;207:506
7) Freedman R, Lewis DA, Michels R, et al.:The initial field trials of DSM-5:new blooms and old thorns. Am J Psychiatry 2013;170:1-5
10) 海老根真由美,斉藤正博,高井泰,他:産後うつ病のスクリーニング-総合周産期母子医療センターでの実施成績.産婦人科の実際 2007;56:943-50
18) 山城雄一郎,和田万里子,永田智:小児の抗癌剤治療に伴う重症粘膜炎のプロバイオティクス治療.医学のあゆみ 2012;243:156-60
20) Jarde A, Lewis-Mikhael AM, Moayyedi P, et al.:Pregnancy outcomes in women taking probiotics or prebiotics:a systematic review and meta-analysis. BMC Pregnancy Childbirth 2018;18:14
11) 宗田聡:EPDS活用ガイド.東京:南山堂,2017
13) Tsankova N, Renthal W, Kumar A, et al.:Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8:355-67
9) IADPSG Consensus Panel:International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82
References_xml – reference: 14) Schroeder FA, Lin CL, Crusio WE, et al.:Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007;62:55-64
– reference: 15) Miyaoka T, Kanayama M, Wake R, et al.:Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder:A prospective open-label trial. Clin Neuropharmacol 2018;41:151-5
– reference: 17) Liu RT, Walsh RFL, Sheehan AE:Prebiotics and probiotics for depression and anxiety:A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev 2019;102:13-23
– reference: 7) Freedman R, Lewis DA, Michels R, et al.:The initial field trials of DSM-5:new blooms and old thorns. Am J Psychiatry 2013;170:1-5
– reference: 8) Logan AC, Katzman M:Major depressive disorder:probiotics may be an adjuvant therapy. Med Hypotheses 2005;64:533-8
– reference: 9) IADPSG Consensus Panel:International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82
– reference: 19) Myhre R, Brantsæter AL, Myking S, et al.:Intake of probiotic food and risk of spontaneous preterm delivery. Am J Clin Nutr 2011;93:151-7
– reference: 16) Slykerman RF, Hood F, Wickens K, et al.:Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: A randomised double-blind placebo-controlled trial. EBioMedicine 2017;24:159-65
– reference: 11) 宗田聡:EPDS活用ガイド.東京:南山堂,2017
– reference: 1) 竹田省:妊産婦の自殺防止.周産期医学 2017;5:623-7
– reference: 10) 海老根真由美,斉藤正博,高井泰,他:産後うつ病のスクリーニング-総合周産期母子医療センターでの実施成績.産婦人科の実際 2007;56:943-50
– reference: 2) Melville JL, Gavin A, Guo Y, et al.:Depressive disorders during pregnancy:prevalence and risk factors in a large urban sample. Obstet Gynecol 2010;116:1064-70
– reference: 4) Lyell DJ, Chambers AS, Steidtmann D, et al.:Antenatal identification of major depressive disorder:a cohort study. Am J Obstet Gynecol 2012;207:506
– reference: 5) 岡野禎治,村田真理子,増地聡子,他:日本版エジンバラ産後うつ病自己評価表(EPDS)の信頼性と妥当性.神科診断学 1996;7:525-33
– reference: 18) 山城雄一郎,和田万里子,永田智:小児の抗癌剤治療に伴う重症粘膜炎のプロバイオティクス治療.医学のあゆみ 2012;243:156-60
– reference: 6) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5):American Psychiatric Association, 2000.
– reference: 12) 光岡知足:プロバイオティクスの歴史と進化.日本乳酸菌学会誌 2011;22:26-37
– reference: 13) Tsankova N, Renthal W, Kumar A, et al.:Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8:355-67
– reference: 20) Jarde A, Lewis-Mikhael AM, Moayyedi P, et al.:Pregnancy outcomes in women taking probiotics or prebiotics:a systematic review and meta-analysis. BMC Pregnancy Childbirth 2018;18:14
– reference: 3) Tam WH1, Chung T:Psychosomatic disorders in pregnancy. Curr Opin Obstet Gynecol 2007;19:126-32
– reference: 21) 古賀泰裕:プロバイオティクス・プレバイオティクスの歴史,概念,適応.臨床と研究 2018;95:937-41
SSID ssib044754511
ssib039893120
ssib058493940
ssj0002672305
ssib041163657
ssib005796665
ssib043658147
Score 2.183173
Snippet Objectives: To elucidate whether the oral administration of probiotics(PRO)during pregnancy is associated with the Edinburgh postnatal depression scale(EPDS)at...
SourceID nii
jstage
SourceType Publisher
StartPage 218
SubjectTerms Edinburgh postnatal depression scale
Maternal postnatal depression
Probiotics
Title A retrospective analysis of the relationship between the oral administration of probiotics during pregnancy and the Edinburgh postnatal depression scale at 1 month after delivery
URI https://www.jstage.jst.go.jp/article/jjspnm/56/2/56_218/_article/-char/en
https://cir.nii.ac.jp/crid/1390004222615375104
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Japan Society of Perinatal and Neonatal Medicine, 2020, Vol.56(2), pp.218-223
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXKcuGCQIBYYJEP3KKUxHGc-FihotWuuqci7S1yGge1pUmVJkK7B34U_w-JGTvNR4UE7MVK7CRtMn4zz_bMmJAPaZZnXhTlbgYDapfzHDAXq8iFSk_nPGZKYTTy4kZcfuFXt-HtZPJr4LXU1Ol0df_HuJKHSBXqQK4YJfsfku0eChVwDPKFEiQM5T_JeOZUuq7KY7SkowYZRozr4NHTbeiRhQ0mLF-N8uYa12eTlMkkbm7DF_eV_oopOe46T8s5GDuzNOPsy0NdmM1HOnfawjmAzDVGSPoOfAaMm2s3If-GDiCjNeQBF74Ck110HqTolodRiebZ-Ls3urQnixNPgGv1XW3Vbu1cl4dmq3sVBm98b3a1waO7ZrvuJpO3TaXAppR5s1sPpzyY1xuih_wbq9gDDopdWG_QqTZ1DKiiCyM-MbQGNs152-vZSLXHA5bAbJT0qQEKOBBStECbw77YTUMxZUl34yitNy4jYqp_6YXAIB6zKPLRI3XxY96rxwjGov0idCCBW_o9u-c-cOnBojWHk9jvR4eYynGYfQ6opgyO2RKRqDARwQA0NFMS7dexC_nmLT6evANQtA0MWDATxaNivR6wsOUz8rTtMnRmsfCcTDbqBfk5oyMc0CMOaJlT6LN0iAPa4sA0IA7oGAd4T48DanFAOxzAszNza4cD2uGA9jigBgdU1dSnBgfU4IAecfCSLD_Pl58u3XYvEncTC-5mabBSTORZJjhuQZEHWcAUY6tU4pxcFOYBEHPFZag1cHgp_JXScIlM4UKh4uAVOSvKQr8mVILujoGkR34GBjT2ZAx0KQuFzFcyDEPvnEj7nZO9zTeTtPolsQJJQpEwU_hx14QhmqARz8kFiCaBrg8ljO08k-KP4aAuAuPL3_yl_S15gnizU4zvyFldNfoCSHedvjdd8zcpeN0F
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+retrospective+analysis+of+the+relationship+between+the+oral+administration+of+probiotics+during+pregnancy+and+the+Edinburgh+postnatal+depression+scale+at+1+month+after+delivery&rft.jtitle=Journal+of+Japan+Society+of+Perinatal+and+Neonatal+Medicine&rft.au=Kawakami+Kosuke&rft.au=Yoshizato+Toshiyuki&rft.au=Okura+Naofumi&rft.date=2020&rft.pub=Japan+Society+of+Perinatal+and+Neonatal+Medicine&rft.issn=1348-964X&rft.eissn=2435-4996&rft.volume=56&rft.issue=2&rft.spage=218&rft.epage=223&rft_id=info:doi/10.34456%2Fjjspnm.56.2_218&rft.externalDocID=130007899052
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1348-964X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1348-964X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1348-964X&client=summon